Newsfeeds - Spark Newswire

6 minute read

Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday’s Mid-Day Session

Today, 6:01 AM

Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.

AEL

2 minute read

Qualys, ShockWave Medical, News Corporation And Some Other Big Stocks Moving Higher On Tuesday

By Lisa Levin

Today, 6:01 AM

Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.

AEL

1 minute read

Analyst Ratings

What To Know About Keefe, Bruyette & Woods’s Downgrade of American Equity Inv

By Benzinga Insights

Today, 6:01 AM

Keefe, Bruyette & Woods downgraded its rating of American Equity Inv (NYSE:AEL) to Market Perform with a price target of $41.00, changing its price target from $43.00 to $41.00. Shares of American Equity Inv are trading down 6.43% over the last 24 hours, at $33.77 per share.

AEL

1 minute read

Analyst Ratings

Where American Equity Inv Stands With Analysts

By Benzinga Insights

Today, 6:01 AM

Over the past 3 months, 4 analysts have published their opinion on American Equity Inv (NYSE:AEL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

AEL

1 minute read

Morgan Stanley Maintains Equal-Weight on American Equity Inv, Lowers Price Target to $40

By Benzinga Newsdesk

Today, 6:01 AM

Morgan Stanley analyst Nigel Dally maintains American Equity Inv (NYSE:AEL) with a Equal-Weight and lowers the price target from $41 to $40.

AEL

1 minute read

Raymond James Maintains Outperform on American Equity Inv, Lowers Price Target to $40

By Benzinga Newsdesk

Today, 6:01 AM

Raymond James analyst C. Gregory Peters maintains American Equity Inv (NYSE:AEL) with a Outperform and lowers the price target from $44 to $40.

AEL

27 minute read

Earnings Scheduled For May 4, 2022

By Benzinga Insights

Today, 6:01 AM

Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.

ABC

2 minute read

Insurance Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

Today, 6:01 AM

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

AEL

1 minute read

Morgan Stanley Maintains Equal-Weight on American Equity Inv, Raises Price Target to $41

By Benzinga Newsdesk

Today, 6:01 AM

Morgan Stanley analyst Bob Huang maintains American Equity Inv (NYSE:AEL) with a Equal-Weight and raises the price target from $40 to $41.

AEL

10 minute read

Earnings Scheduled For February 17, 2022

By Benzinga Insights

Today, 6:01 AM

Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million.

AAWW